EASTHAM GROUP PRACTICE
47 BRIDLE ROAD, BROMBOROUGH, WIRRAL
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 25 | 31 | 80.6% | |
| HF 4 | 2011 | 27 | 40 | 67.5% | |
| HF 4 | 2012 | 36 | 49 | 73.5% | |
| HF 4 | 2013 | 43 | 52 | 82.7% | |
| HF004 | 2014 | 20 | 25 | 80.0% | |
| HF004 | 2015 | 35 | 38 | 92.1% | |
| HF004 | 2016 | 36 | 40 | 90.0% | |
| HF004 | 2017 | 34 | 40 | 85.0% | |
| HF004 | 2018 | 44 | 52 | 84.6% | |
| HF004 | 2019 | 53 | 66 | 80.3% | |
| HF004 | 2020 | 73 | 91 | 80.2% | |
| HF006 | 2021 | 104 | 124 | 83.9% | |
| HF006 | 2022 | 161 | 192 | 83.9% | |
| HF006 | 2023 | 173 | 191 | 90.6% |
